Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ABBOTT LABORATORIES Hits Price Target Forecast with 14.54% Profit

February 05, 2025
On November 15, 2024, QuantWave's automated forecasting platform generated a long signal for ABBOTT LABORATORIES with the stock trading at 114.76 $. This forecast proved to be highly accurate as the target price of 131.45 $ was reached on February 5, 2025, resulting in a profit of 14.54%.

The success of this forecast can be attributed to several factors. ABBOTT LABORATORIES has been showing strong financial performance, with steady revenue growth and positive developments in its product pipeline. In addition, the healthcare sector, in which ABBOTT LABORATORIES operates, has been receiving increased attention from investors due to the ongoing global health crisis, creating a favorable market environment for the stock.

This achievement showcases the effectiveness of QuantWave's advanced analytics and forecasting capabilities. By harnessing cutting-edge technology and data-driven algorithms, QuantWave provides users with accurate predictions for a wide range of stocks, offering opportunities for significant profits.

For investors looking to enhance their understanding of QuantWave's investment strategy, QuantSchool provides a comprehensive educational framework. QuantSchool equips users with the essential principles for generating consistent income using the QuantWave forecasting system, empowering them to make informed investment decisions.

Overall, the successful price target forecast for ABBOTT LABORATORIES highlights the potential of QuantWave's forecasting platform in helping investors achieve their financial goals.
If you want to leave a comment, then you need Login or Register





Other data for ABT

Related data

ABTAugust 9, 2025Abbott Laboratories NYSE:ABT Earnings Are Of Questionable Quality  ~1 min.

Abbott Laboratories recently reported their second quarter 2025 earnings, with EPS exceeding expectations....


ABTJune 5, 2025Abbott Laboratories ABT is Attracting Investor Attention: Here is What You Should Know  ~1 min.

Abbott Laboratories (ABT) has been making waves in the healthcare sector, attracting attention from investors around the globe....


ABTMarch 18, 2025Abbott Laboratories Continues to Drive Growth in the Healthcare Sector  ~2 min.

Abbott Laboratories (ABT) has emerged as a top player in the healthcare industry, making it an attractive stock for long-term investors....


ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....


ABTMarch 16, 2025Abbott Laboratories: Breaking New Ground in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making waves in the healthcare industry with its groundbreaking innovations....


ABTMarch 15, 2025Abbott Laboratories: A Healthcare Stock With Long-Term Investment Potential  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has been delivering groundbreaking medical technologies and products for decades....


ABTFebruary 26, 2025Abbott Laboratories Continues to Deliver Strong Earnings Growth  ~2 min.

Abbott Laboratories, a leading global healthcare company, has reported steady growth in earnings over the past five years....


ABTFebruary 22, 2025Abbott Laboratories: A Rising Star in the Pharmaceutical Industry  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making significant progress in the pharmaceutical industry, positioning itself as one of the best drug stocks to buy now....


ABTFebruary 21, 2025Abbott Laboratories NYSE:ABT: A Leading Drug Stock with Promising Future  ~1 min.

Abbott Laboratories, a renowned pharmaceutical company, has emerged as one of the best drug stocks to invest in....


ABTFebruary 21, 2025ABBOTT LABORATORIES Stock Hits Price Target with 16.11% Profit: QuantWave Forecast Success  ~2 min.

On December 2, 2024, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock when it was trading at 115.66 $....


ABTJanuary 24, 2025ABBOTT LABORATORIES Hits Price Target Forecast with 14.8% Profit - QuantWave Analysis  ~2 min.

Abbott Laboratories' stock reached the forecasted price target of 124.45 $ on January 24, 2025, generating a profit of 14....


ABTOctober 12, 2023ABBOTT LABORATORIES Hits Forecast Price Target with 10.91% Profit, Confirming QuantWave's Accuracy  ~2 min.

Abbott Laboratories (NYSE: ABT) recently achieved the forecast price target set by QuantWave, signaling a profitable short position for investors....


ABTFebruary 20, 2025ABBOTT LABORATORIES Achieves Price Target Forecast with 15.9% Profit  ~1 min.

QuantWave's forecast for ABBOTT LABORATORIES reached its target on February 20, 2025, generating a profit of 15.9%. The forecast signal date was December 10th, 2024, with a price of $114....


ABTFebruary 20, 2025ABBOTT LABORATORIES Stock Hits Price Target Forecast with 15.12% Profit, QuantWave Analysis Shows Strong Predictive Power  ~2 min.

ABBOTT LABORATORIES (NYSE: ABT) investors reaped substantial gains as the stock price hit the forecasted target of 132.56 $ on February 20, 2025, resulting in a profit of 15.12%....


ABTJanuary 23, 2025ABBOTT LABORATORIES Hits Price Target Forecast on QuantWave, Generating 14.94% Profit  ~1 min.

On January 23, 2025, ABBOTT LABORATORIES (ABT) successfully reached the price target forecast set by QuantWave, hitting $122.1 from the initial price of $106.24 on August 1, 2023....